Free Trial

DocGo (NASDAQ:DCGO) Sets New 52-Week High - Here's What Happened

DocGo logo with Medical background

DocGo Inc. (NASDAQ:DCGO - Get Free Report)'s share price reached a new 52-week high during trading on Friday . The company traded as high as $5.12 and last traded at $5.07, with a volume of 474908 shares. The stock had previously closed at $4.85.

Analysts Set New Price Targets

Separately, Needham & Company LLC reiterated a "buy" rating and issued a $7.00 price target on shares of DocGo in a report on Thursday, January 16th. Five equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company has a consensus rating of "Buy" and a consensus target price of $6.10.

View Our Latest Stock Analysis on DocGo

DocGo Trading Up 4.2 %

The firm has a market cap of $505.15 million, a PE ratio of 17.68, a price-to-earnings-growth ratio of 13.77 and a beta of 1.00. The company has a 50-day simple moving average of $4.36 and a 200 day simple moving average of $3.83.

DocGo (NASDAQ:DCGO - Get Free Report) last announced its quarterly earnings results on Thursday, November 7th. The company reported $0.05 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.04 by $0.01. DocGo had a net margin of 4.35% and a return on equity of 8.90%. The firm had revenue of $138.68 million for the quarter, compared to the consensus estimate of $139.59 million. During the same period in the prior year, the firm posted $0.05 earnings per share. On average, equities analysts expect that DocGo Inc. will post 0.25 earnings per share for the current year.

Insider Buying and Selling

In other news, General Counsel Ely D. Tendler sold 23,088 shares of the firm's stock in a transaction that occurred on Monday, December 16th. The stock was sold at an average price of $4.44, for a total value of $102,510.72. Following the transaction, the general counsel now owns 175,645 shares in the company, valued at $779,863.80. This trade represents a 11.62 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 2.70% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in DCGO. WCM Investment Management LLC raised its position in shares of DocGo by 64.2% in the fourth quarter. WCM Investment Management LLC now owns 4,314,071 shares of the company's stock valued at $18,637,000 after buying an additional 1,687,100 shares during the last quarter. Geode Capital Management LLC raised its holdings in DocGo by 1.8% in the 3rd quarter. Geode Capital Management LLC now owns 2,252,516 shares of the company's stock valued at $7,480,000 after acquiring an additional 39,016 shares during the last quarter. State Street Corp lifted its stake in DocGo by 4.9% in the 3rd quarter. State Street Corp now owns 1,928,972 shares of the company's stock worth $6,404,000 after purchasing an additional 90,438 shares in the last quarter. P.A.W. Capital Corp boosted its holdings in shares of DocGo by 1.9% during the 3rd quarter. P.A.W. Capital Corp now owns 1,630,000 shares of the company's stock worth $5,412,000 after purchasing an additional 30,000 shares during the last quarter. Finally, Harbor Capital Advisors Inc. boosted its holdings in shares of DocGo by 37.5% during the 4th quarter. Harbor Capital Advisors Inc. now owns 1,331,928 shares of the company's stock worth $5,647,000 after purchasing an additional 363,391 shares during the last quarter. Hedge funds and other institutional investors own 56.44% of the company's stock.

DocGo Company Profile

(Get Free Report)

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.

Featured Stories

Should You Invest $1,000 in DocGo Right Now?

Before you consider DocGo, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocGo wasn't on the list.

While DocGo currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines